Plain-English translation of NCT05038332 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Prostate Cancer research guide โPhase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a much shorter course of radiation therapy works as well as the standard longer course for men whose prostate cancer has come back after surgery. You would receive either 20 radiation treatments over 5-6 weeks, or just 5 treatments over 3-4 weeks. The goal is to find out if the shorter treatment is just as effective but easier for patients to complete.
Current radiation therapy after prostate surgery takes 4-8 weeks, which is a heavy burden for patients and may prevent some men from getting this potentially life-saving treatment. A much shorter schedule could make it easier for patients to receive this important therapy.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this trial, you will be randomly assigned to one of two treatment groups. One group will receive radiation therapy 20 times over 5-6 weeks; the other will receive it just 5 times over 3-4 weeks. You will need to provide tissue samples from your original prostate surgery for review, complete quality-of-life surveys, and attend all your radiation appointments. The entire study will take several weeks to a couple of months depending on which group you're in.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
United States